These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26219494)

  • 1. Slowing the progression of Alzheimer's disease; what works?
    Nelson L; Tabet N
    Ageing Res Rev; 2015 Sep; 23(Pt B):193-209. PubMed ID: 26219494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease.
    Chang CY; Silverman DH
    Expert Rev Mol Diagn; 2004 Jan; 4(1):63-9. PubMed ID: 14711350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet and Alzheimer's disease risk factors or prevention: the current evidence.
    Solfrizzi V; Panza F; Frisardi V; Seripa D; Logroscino G; Imbimbo BP; Pilotto A
    Expert Rev Neurother; 2011 May; 11(5):677-708. PubMed ID: 21539488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caloric intake and Alzheimer's disease. Experimental approaches and therapeutic implications.
    Pasinetti GM; Zhao Z; Qin W; Ho L; Shrishailam Y; Macgrogan D; Ressmann W; Humala N; Liu X; Romero C; Stetka B; Chen L; Ksiezak-Reding H; Wang J
    Interdiscip Top Gerontol; 2007; 35():159-75. PubMed ID: 17063038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
    Kidd PM
    Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer's disease?
    Brown BM; Peiffer JJ; Martins RN
    Mol Psychiatry; 2013 Aug; 18(8):864-74. PubMed ID: 23164816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the treatment of vascular risk factors slow cognitive decline in Alzheimer's disease patients?
    Richard F; Pasquier F
    J Alzheimers Dis; 2012; 32(3):765-72. PubMed ID: 22886010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Alzheimer's disease: the next 10 years.
    Hampel H; Prvulovic D; Teipel S; Jessen F; Luckhaus C; Frölich L; Riepe MW; Dodel R; Leyhe T; Bertram L; Hoffmann W; Faltraco F;
    Prog Neurobiol; 2011 Dec; 95(4):718-28. PubMed ID: 22137045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on clinical proteomics in Alzheimer's research.
    Korolainen MA; Nyman TA; Aittokallio T; Pirttilä T
    J Neurochem; 2010 Mar; 112(6):1386-414. PubMed ID: 20050976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The basis for disease-modifying treatments for Alzheimer's disease: the Sixth Annual Mild Cognitive Impairment Symposium.
    Duara R; Barker W; Loewenstein D; Bain L
    Alzheimers Dement; 2009 Jan; 5(1):66-74. PubMed ID: 19118811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective pharmacological management of Alzheimer's disease.
    Atri A
    Am J Manag Care; 2011 Nov; 17 Suppl 13():S346-55. PubMed ID: 22214392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease.
    Cummings JL; Miller BL; Christensen DD; Cherry D
    CNS Spectr; 2008 Feb; 13(2 Suppl 2):1-20; quiz 22. PubMed ID: 18264030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowering the risk of Alzheimer's disease: evidence-based practices emerge from new research.
    Jedrziewski MK; Lee VM; Trojanowski JQ
    Alzheimers Dement; 2005 Oct; 1(2):152-60. PubMed ID: 19595848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
    Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
    Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memorcise and Alzheimer's disease.
    Loprinzi PD; Frith E; Ponce P
    Phys Sportsmed; 2018 May; 46(2):145-154. PubMed ID: 29480042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do cholinesterase inhibitors slow progression of Alzheimer's disease?
    Farlow MR
    Int J Clin Pract Suppl; 2002 Jun; (127):37-44. PubMed ID: 12139366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Alzheimer's disease: the current situation?].
    Jacquy J
    Rev Med Brux; 2010 Sep; 31(4):357-62. PubMed ID: 21089415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.